4Tohgi H,Konno S,Takahashi S.Activated coagulation fibrinolysis system and platelet function in acute thrombotic stroke patients with increased Creactiveprotein levels.Thromb Res,2000,26:100.
5Charuruks N,Laohajinda B,Rujiwanitgum S,et al.Reference value for Creactive protein and its distribution pattern in Thai adults.Circ J,2005,69:339-344.
6Dowling NF,Hooper WC,Austin H,et al.Understanding and predicting venous thromboembolism:the role of coagulation factor and inflammatory markers.Am J Med,2002,113:689-690.
7Folsom AR,Lutsey PL,Astor BC,et al.Creactive protein and venous thromboembolism.A prospective investigation in the ARIC cohort.Thromb Haemost,2009,102:615-616.
9GEERTS WH, PINEO GF, HEIT JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy[J]. Chest, 2004, 126(3 Suppl): 338S-400S.
10SOLOMON ER, FRICK AC, PARAISO MF, et al. Risk of deep venous thrombosis and pulmonary embolism in urogynecologic surgical patients[J]. Am J Obstet Gynecol, 2010, 203(5): 510.
